Abstract
There are well known differences between children and adults in both the incidence of different types of acute leukemia and the response to treatment. Whereas acute lymphoblastic leukemia (ALL) constitutes 85–90% of cases of acute leukemia in children, the converse is true in adults, approximately 85% of whom have acute myeloid leukemia. There are no proven explanations for this discrepancy in incidence, although it has been postulated that the antigenic stimulation of new clones of lymphocytes during the maturation of the immune system in infants and children may be associated with an increased mutation rate and hence leukemias occurring in cells of lymphoid lineage (1). There are also major differences in responsiveness to therapy, particularly in ALL where there is a progressive age related decline in both initial complete response rate as well as long term disease free survival; adolescents fare more poorly than younger children with subsequent decreases in survival with advancing patient age in adults (Figure l)(2–8).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Greaves, M.F. Speculations on the causes of childhood acute lymphoblastic leukemia. Leukemia 2:120 (1988).
Gaynor, J., Chapman, D., Little, C., McKenzie, S., Miller, W., Andreeff, M., Arlin, Z., Berman, E., Kempin, S., Gee, T., Clarkson, B. A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the memorial hospital experience since 1969. J. Clin. Oncol. 6:1014 (1988).
Baccarani, M., Carbelli, G., Amadori, S., Drenthe-Schonk, A., Willemze, R., Meloni, G., Cardozo, P.L., Haanen, C., Mandelli, F., Tura, S. Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood 60:677 (1982).
Crist, W., Pullen, J., Boyett, J., Falletta, J., van Eys, J., Borowitz, M., Jackson, J., Dowell, B., Russell, C., Quddus, F., Ragab, A., Vietti, T. Acute lymphoid leukemia in adolescents: clinical and biologic features predict a poor prognosis-a Pediatric Oncology Group study. J. of Clin. Onc. 6:34 (1987).
Linker, C.A., Levitt, L.J., O’Donnell, M., Reis, C.A., Link, M.P., Forman, S.J., Farbstein, M.J. Improved results of treatment of adult acute lymphoblastic leukemia. Blood 69:1242 (1987).
Gottlieb, A.J., Weinberg, V., Ellison, R.R., Henderson, E.S., Terebelo, H., Rafla, S., Cuttner, J., Silver, R.T., Carey, R.W., Levy, R.N., Hutchinson, J.L., Raich, P., Cooper, M.R., Wiernik, P., Anderson, J.R., Holland, J.F. Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by Cancer and Leukemia Group B. Blood 64:267 (1984).
Ellison, P.R., Mick, R., Cuttner, J., Schiffer, C., Sobol, R. Prognostic factors affecting response and survival in adults with acute lymphocytic leukemia treated on CALGB 8011. Proc. Am. Soc. Clin. Oncol. 5:156 (1986).
Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Diedrich, H., Ruhl, H., Maschmeyer, G., Lipp, T., Nowrousian, M.R., Burkert, M., Gerecke, D., Pralle, H., Muller, U., Lunscken, C.H., Fulle, H., Ho, A.D., Kuchler, R., Busch, F.W., Schneider, W., Gorg, C.H., Emmerich, B., Braumann, D., Vaupel, H.A., von Paleske, A., Bartels, H., Neiss, A., Messerer, D. Progostic factors in multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123 (1988).
Schiffer, C.A., Wade, J.A. Supportive Care: Issues in the use of blood products and treatment of infection. Semin. Oncol. 14:454 (1987).
Mayer, R.J., Schiffer, C.A., Peterson, B.A., Silver, R.T., Cornwell, G.G., Rai, K.R., Ellison, R.R., Maguire, M., Berg, D., Davis, R.B., Mclntyre, O.R., Frei, E. Intensive post-remission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of Ara-C: A progress report from the CALGB. Semin. Oncol. 14:25–31 (1987).
Preisler, H., Davis, R.B., Kirshner, J., Dupre, E., Richards, III F., Hoagland, H.C., Kopel, S., Levy, R.N., Carey, R., Schulman, P., Gottleib, A.J., Mclntyre, O.R., and the Cancer and Leukemia Group B. Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: A Cancer and Leukemia Group B study. Blood 69:1441 (1987).
Rai, K.R., Holland, J.F., Glidewell, O.J., Weinberg, V., Brunner, K., Obrecht, J.P., Preisler, H.D., Nawabi, I.W., Prager, D., Carey, R.W., Cooper, M.R., Haurani, F., Hutchinson, J.L., Silver, R.T., Falkson, G., Wiernik, P., Hoagland, H.C., Bloomfield, C.D., James, G.W., Gottlieb, A., Ramanan, S.V., Blom, J., Nissen, N.I., Bank, A., Ellison, R.R., Kung, F., Henry, P., Mclntyre, O.R., Kaan, S.K. Treatment of acute myelocytic leukemia: a study by Cancer and Leukemia Group B. Blood 58:1203 (1981).
Schiffer, C.A., Mayer, R.J. for CALGB, Cancer and Leukemia Group B (CALGB) Studies in Acute Myeloid Leukemia. In: Acute Myelogenous Leukemia. R.P. Gale (eds), Wiley/Liss (in press).
Berger, R., Bemheim, A., Ochoa-Noguera, M.E., Daniel, M.T., Valensi, F., Sigaux, F., Flandrin, G., Boiron, M. Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients. Can. Genet. Cytogenet. 28:293 (1987).
Fourth International Workshop on Chromosomes in Leukemia, 1982. Clinical significance of chromosomal abnormalities in acute non-lymphoblastic leukemia. Can. Genet. Cytogenet. 11:332 (1984).
Keating, M.J., Cork, A., Broach, Y., Smith, T., Walters, R.S., McCredie, K.B., Trujillo, J., Freireich, E.J. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leukemia Res. 11:119 (1987).
Samuels, B.L., Larson, R.A., Le Beau, M.M., Daly, K.M., Bitter, M.A., Vardiman, J.W., Barker, C.M., Rowley, J.D., Golomb, H.M. Specific chromosomal abnormalties in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia 2:79 (1988).
Schiffer, C.A., Lee, E.J., Tomiyasu, T., Wiernik, P.H., Testa, J.R. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia Blood 73:263 (1989).
Rowley, J.D. Association of specific chromosome abnormalities with type of acute leukemia and with patient age. Can. Res. 41:3407 (1981).
Golomb, H.M., Alimena, G., Rowley, J.D. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood 60:404 (1982).
Keinänen, M., Griffin, J.D., Bloomfield, C.D., Machnicki, J., de la Chapelle, A. Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. New England J Medicine 318:1153 (1988).
Lee, E.J., Pollak, A., Leavitt, R.D., Testa, J.R., Schiffer, C.A. Minimally differentiated acute nonlymphocytic leukemia: A distinct entity. Blood 70:1400 (1987).
Vaughan, W.P., Civin, C.I., Weisenburger, D.D., Karp, J.E., Graham, M.L., Sanger, W.G., Grierson, H.L., Joshi, S.S., Burke, P.J. Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). Leukemia 2:661 (1988).
Borowitz, M.J., Gockerman, J.P., Moore, J.O., Civin, C.I., Page, S.O., Robertson, J., Bigner, S.H. Clinicopathologic and cytogenetic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. Am. J. Clin. Pathol. 91:265 (1989).
Moscow, J.A., Cowan, K.H. Review: Multidrug resistance. J. Natl. Cancer Inst. 80:14 (1988).
Sobol, R.E., Royston, I., LeBien, T.W., Minowada, J., Anderson, K., Davey, F.R., Cuttner, J., Schiffer, C., Ellison, R.R., Bloomfield, C.D, Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood 64:730 (1985).
Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Freund, M., Ganser, A., Heil, G., Hiddemann, W., Maschmeyer, G., Aul, C., Wendt, F.C., Bross, K., Pralle, H., Kuchler, R., Dietrich, H., Mettnernich, M., Lindemann, A., Lipp, T., Kaboth, W., Nowrousian, M.R., Koch, P., Busch, F.W., Heimpel, H., Gotz, G., Weiss, A., Kolb, H., Messerer, D. Intensification chemotherapy and mediastinal irradiation in adult T-cell acute lymphoblastic leukemia. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 221-229 (1990).
Sobol, R.E., Rosemarie, M., Royston, I., Davey, F.R., Ellison, R.R., Newman, R., Cuttner, J., Griffin, J.D., Collins, H., Nelson, D.A., Bloomfield, C.D. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. New Eng. J. Med. 316:1111(1987).
Mirro, J., Zipf, T.F., Pui, C-H., Kitchingman, G., Williams, D., Melvin, S., Murphy, S.B., Stass, S. Acute Mixed Lineage Leukemia: clinicopathologic correlations and prognostic significance. Blood 66:1115 (1985).
Schiffer, C.A. Hybrid Leukemias. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 129-142 (1990).
Ball, E.D., Griffin, J.D., Davis, R., Davey, F.R., Arthur, D., Wurster-Hill, D., Schiffer, C., Bloomfield, C.D. Prognostic value of lymphocyte surface markers in acute myeloid leukemia (AML): A Cancer and Leukemia Group B (CALGB) Study. Blood 72:187 (1988).
Williams, D.L., Raimondi, S.C., Pui, C-H., Rivera, G.K. Evolving chromosome patterns and new cytogenetic concepts in childhood acute lymphoblastic leukemia. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 91-100 (1990).
Williams, D.L., Harber, J., Murphy, S.B., Look, T.A., Kalwinksy, D.K., Rivera, G., Melvin, S.L., Stass, S., Dahl, G.V. Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 68:205 (1986).
Crist, W., Carroll, A., Shuster, J., Jackson, J., Head, D., Borowitz, M., Behm, F., Link, M., Steuber, P., Ragab, A., Hirt, A., Brock, B., Land, V., Pullen, J. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A pediatric oncology group study. Blood 76:489 (1990).
Bloomfield, C.D., Goldman, A.I., Alimena, G., Berger, R., Borgstrom, G.H., Brandt, L., Catovsky, D., de la Chapelle, A., Dewald, G.W., Garson, O.M., Garwicz, S., Golomb, H.M., Hossfeld, D.K., Lawler, S.D., Mitelman, F., Nilsson, P., Pierre, R.V., Philip, P., Prigogina, E., Rowley, J.D., Sakurai, M., Sandberg, A.A., Secker Walker, L.M., Tricot, G., Van Den Berghe, H., Van Orshoven, A., Vuopio, P., Whang-Peng, J. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 67:415 (1986).
Kurzrock, R., Gutterman, J.U., Talpaz, M. The molecular genetics of Philadelphia chromosome-positive leukemias. New Eng. J. Med., 319:990 (1988).
Hooberman, A.L., Rubin, C.M., Barton, K.P., Westbrook, C.A. Detection of the Philadelphia chromosome in acute lymphoblastic leukemia by pulsed-field gel electorphoresis. Blood 74:1101 (1989).
Hooberman, A.L., Westbrook, C.A., Davey, F., Schiffer, G., Spino, G., Bloomfield, C.D. Molecular detection of the Philadelphia chromosome (PH1) chromosome in adult acute lymphoblastic leukemia (ALL): clinical cytogenetic, and immunophenotypic correlations in a CALGB study. Blood 74:183 (1989).
Bloomfield, C.D., Wurster-Hill, D., Peng, G., Le Beau, M., Tantravahi, R., Testa, J., Davey, F.R., Ellison, R.R., Cuttner, J., Schiffer, C., Sobol, R.E., Lunghofer, B., Carey, M., Mick, R., Arthur, D. Prognostic significance of the Philadelphia chromosome in adult acute lymphoblastic leukemia. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 101-109 (1990).
Forman, S.J., O’Donnell, M.R., Nademanee, A.P. Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 70:587 (1987).
Evans, W.E., Crom, W.R., Abromowitch, M., Dodge, R., Look, A.T., Bowman, W.P., George, S.L., Pui, C.H. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. New Eng. J. Med. 314:471 (1986).
Lennard, L., Lilleyman, J.S. Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J. Clin. Oncol. 7:1816 (1989).
Capizzi, R.L., Oliver, L., Friedman, J., Davis, R., Mayer R., Schiffer, C.A. Variations in Ara-C plasma concentrations at steady-state (C-ss) during remission induction and intensification therapy of AML. A population pharmacokinetics study by CALGB. Proc. Amer. Soc. Clin. Onc. 7:57 (1988).
Clavell, L.A., Gelber, R.D., Cohen, HJ., Hitchcock-Bryan, S., Cassady, J.R., Tarbeil, N.J., Blattner, S.R., Tantravahi, R., Leavitt, P., Sallan, S.E. Fouragent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. New Eng. J. Med. 315:657 (1986).
Steinherz, P.G., Gaynon, P., Miller, D.R., Reaman, G., Bleyer, A., Finklestein, J., Evans, R.G., Meyers, P., Steinherz, L.J., Sather, H., Hammond, D. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen — a new intensive therapy protocol: a report from the Children’s Cancer Study Group. J. of Clin. Onc. 4:744 (1986).
LeBien, T.W., McCormack, T. The common acute lymphoblastic leukemia antigen (CD10): emancipation from a functional enigma. Blood 73:625 (1989).
Barrett, J.A., Horowitz, M.M., Gale, R.P., Biggs, J.C., Camitta, B.M., Dicke, K.A., Gluckman, E., Good, R.A., Herzig, H., Lee, M.B., Marmont, A.M., Masaoka, T., Ramsay, N.K.C., Rimm, A.A., Speck, B., Zwaan, F.E., Bortin, M.M. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 74:862 (1989).
Groopman, J.E., Molina, J.M., Scadden, D.T. Hematopoietic growth factors: biology and clinical applications. New Eng. J. Med. 321:1449 (1989).
Büchner, T., Hiddemann, W., Koenigsmann, M., Zuhlsdorf, M., Wormann, B., Boeckmann, A., van de Loo, J., Maschmeyer, G., Wendt, F., Schulz, G. Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) for acute leukemias in aplasia and at high risk of early death. Blood 72:111a (1989).
Muhm, M., Andreeff, M., Geissler, K., Gorischek, C., Haas, O., Haimi, J., Hinterberger, W., Schulz, G., Speiser, W., Sunder-Plassmann, G., Valent, P., Lechner, K., Bettelheim, P. RhGM-CSF in combination with chemotherapy — a new strategy in the therapy of acute myeloid leukemia. Blood 74:117a (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schiffer, C.A., McIntyre, O.R. (1993). Age Related Changes in Adults with Acute Leukemia. In: Yang, S.S., Warner, H.R. (eds) The Underlying Molecular, Cellular and Immunological Factors in Cancer and Aging. Advances in Experimental Medicine and Biology, vol 330. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2926-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2926-2_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6270-8
Online ISBN: 978-1-4615-2926-2
eBook Packages: Springer Book Archive